In our study, tumors with SPRY2 knockdown (upper row, Figure 5C) had remarkably larger sizes than these without SPRY2 knockdown (lower row, Figure 5C) (Figure 5D), confirming the suppressor role of SPRY2 in gastric tumor growth. The gene discussed is SPRY2; the disease is gastric neoplasm.